Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
HighLife raised more than USD 90 million (EUR 80 million) in a private financing round to fund a US pivotal study. Proceeds also target faster commercial expansion in Europe following CE Mark clearance for its transcatheter mitral valve replacement system. Round was co-led by Andera Partners, Sofinnova Partners, Supern
HighLife, a Paris-based developer of a transcatheter mitral valve replacement system, raised over EUR 80 million in a private financing round co-led by Sofinnova Partners. The funds will support a US pivotal study, European commercial rollout, and organizational growth. The company recently secured a CE mark for its TM